:: Class Utilisation Summary 2008
See LEGEND for key to shading and symbols.
:: Subject Area - PHPH Term - Semester 1
Data is correct as at Wed Oct 22 02:00:12 EST 2008
Comp | Sect | Class | Type | Status | Enr/Cap | % Full | Times (weeks, Location) - default 1hour |
PHPH2101 | Physiology 1A | ||||||
LAB | T10A | 5287 | Enr | Full | 36/27 [30] | > 100% | Tue 10-13 (MedLb M210) Comb/w PHPH2121 PHPH2501 |
LAB | T10B | 5288 | Enr | Closed | 0/25 | 0% | Tue 10-13 (MedCL M211) Comb/w PHPH2121 PHPH2501 |
LAB | T10C | 5289 | Enr | Full | 53/53 | 100% | Tue 10-13 (Wurth 204) |
LAB | T14A | 5281 | Enr | Full | 42/31 [38] | > 100% | Tue 14-17 (Wurth 204) Comb/w PHPH2121 PHPH2501 |
LAB | T14B | 5282 | Enr | Full | 50/46 [48] | > 100% | Tue 14-17 (Wurth 202) Comb/w PHPH2121 PHPH2501 |
LAB | T14C | 5283 | Enr | Open | 34/36 | 94% | Tue 14-17 (MedLb M210) Comb/w PHPH2121 PHPH2501 |
LAB | W10A | 5284 | Enr | Full | 33/14 [50] | > 100% | Wed 10-13 (MedLb M210) Comb/w PHPH2121 PHPH2501 |
LAB | W10B | 5285 | Enr | Open | 42/44 [60] | 95% | Wed 10-13 (Wurth 202) Comb/w PHPH2121 PHPH2501 |
LAB | W10C | 5286 | Enr | Open | 30/32 [45] | 94% | Wed 10-13 (Wurth 204) Comb/w PHPH2121 PHPH2501 |
LEC | A | 5280 | Rel | Full | 320/284 [300] | > 100% | Tue 17 (MathewsThA); Wed 09 (MathewsThA); Fri 09 (CLB 7) Comb/w PHPH2121 PHPH2501 |
TUT | W09A | 5290 | Rel | Full | 64/58 [75] | > 100% | Wed 09 (w2,4,6,9-10,12, MathewsThA) Comb/w PHPH2121 PHPH2501 |
TUT | W09B | 5291 | Rel | Full | 41/41 [75] | 100% | Wed 09 (w2,4,6,9-10,12, Biomed ThC) Comb/w PHPH2121 PHPH2501 |
TUT | W09C | 5292 | Rel | Open | 52/53 [75] | 98% | Wed 09 (w2,4,6,9-10,12, Biomed ThD) Comb/w PHPH2121 PHPH2501 |
TUT | W09D | 5293 | Rel | Full | 55/42 [75] | > 100% | Wed 09 (w2,4,6,9-10,12, Biomed ThF) Comb/w PHPH2121 PHPH2501 |
TUT | W09E | 5294 | Rel | Full | 59/46 [75] | > 100% | Wed 09 (w2,4,6,9-10,12, Biomed ThA) Comb/w PHPH2121 PHPH2501 |
TUT | W09F | 5295 | Rel | Open | 49/54 [75] | 91% | Wed 09 (w2,4,6,9-10,12, Biomed ThE) Comb/w PHPH2121 PHPH2501 |
PHPH2121 | Principles of Physiology A | ||||||
LAB | T10A | 5303 | Enr | Open | 6/0 [3] | N/A | Tue 10-13 (MedLb M210) Comb/w PHPH2101 PHPH2501 |
LAB | T10B | 5304 | Enr | Closed | 0/25 | 0% | Tue 10-13 (MedCL M211) Comb/w PHPH2101 PHPH2501 |
LAB | T10C | 5305 | Enr | Full | 2/2 | 100% | Tue 10-13 (Wurth 204) |
LAB | T14A | 5297 | Enr | Full | 17/6 [12] | > 100% | Tue 14-17 (Wurth 204) Comb/w PHPH2101 PHPH2501 |
LAB | T14B | 5298 | Enr | Full | 9/5 [8] | > 100% | Tue 14-17 (Wurth 202) Comb/w PHPH2101 PHPH2501 |
LAB | T14C | 5299 | Enr | Full | 7/7 | 100% | Tue 14-17 (MedLb M210) Comb/w PHPH2101 PHPH2501 |
LAB | W10A | 5300 | Enr | Open | 8/0 [60] | N/A | Wed 10-13 (MedLb M210) Comb/w PHPH2101 PHPH2501 |
LAB | W10B | 5301 | Enr | Open | 10/12 [60] | 83% | Wed 10-13 (Wurth 202) Comb/w PHPH2101 PHPH2501 |
LAB | W10C | 5302 | Enr | Open | 5/7 [45] | 71% | Wed 10-13 (Wurth 204) Comb/w PHPH2101 PHPH2501 |
LEC | A | 5296 | Rel | Full | 64/28 [55] | > 100% | Tue 17 (MathewsThA); Wed 09 (MathewsThA); Fri 09 (CLB 7) Comb/w PHPH2101 PHPH2501 |
TUT | W09A | 5306 | Rel | Full | 9/3 [75] | > 100% | Wed 09 (w2,4,6,9-10,12, MathewsThA) Comb/w PHPH2101 PHPH2501 |
TUT | W09B | 5307 | Rel | Full | 4/4 [75] | 100% | Wed 09 (w2,4,6,9-10,12, Biomed ThC) Comb/w PHPH2101 PHPH2501 |
TUT | W09C | 5308 | Rel | Open | 7/8 [75] | 88% | Wed 09 (w2,4,6,9-10,12, Biomed ThD) Comb/w PHPH2101 PHPH2501 |
TUT | W09D | 5309 | Rel | Full | 18/5 [75] | > 100% | Wed 09 (w2,4,6,9-10,12, Biomed ThF) Comb/w PHPH2101 PHPH2501 |
TUT | W09E | 5310 | Rel | Full | 15/2 [75] | > 100% | Wed 09 (w2,4,6,9-10,12, Biomed ThA) Comb/w PHPH2101 PHPH2501 |
TUT | W09F | 5311 | Rel | Open | 11/16 [75] | 69% | Wed 09 (w2,4,6,9-10,12, Biomed ThE) Comb/w PHPH2101 PHPH2501 |
PHPH2501 | Human Physiology A | ||||||
LAB | T10A | 6220 | Enr | Full | 17/8 [16] | > 100% | Tue 10-13 (MedLb M210) Comb/w PHPH2101 PHPH2121 |
LAB | T10B | 6221 | Enr | Closed | 0/10 | 0% | Tue 10-13 (MedCL M211) Comb/w PHPH2101 PHPH2121 |
LAB | T10C | 6222 | Enr | Full | 4/4 | 100% | Tue 10-13 (Wurth 204) |
LAB | T14A | 6214 | Enr | Full | 12/1 [10] | > 100% | Tue 14-17 (Wurth 204) Comb/w PHPH2101 PHPH2121 |
LAB | T14B | 6215 | Enr | Full | 5/1 [4] | > 100% | Tue 14-17 (Wurth 202) Comb/w PHPH2101 PHPH2121 |
LAB | T14C | 6216 | Enr | Open | 2/3 | 67% | Tue 14-17 (MedLb M210) Comb/w PHPH2101 PHPH2121 |
LAB | W10A | 6217 | Enr | Full | 38/19 [60] | > 100% | Wed 10-13 (MedLb M210) Comb/w PHPH2101 PHPH2121 |
LAB | W10B | 6218 | Enr | Open | 6/8 [60] | 75% | Wed 10-13 (Wurth 202) Comb/w PHPH2101 PHPH2121 |
LAB | W10C | 6219 | Enr | Open | 8/10 [45] | 80% | Wed 10-13 (Wurth 204) Comb/w PHPH2101 PHPH2121 |
LEC | A | 6213 | Rel | Full | 92/56 [85] | > 100% | Tue 17 (MathewsThA); Wed 09 (MathewsThA); Fri 09 (CLB 7) Comb/w PHPH2101 PHPH2121 |
TUT | W09A | 6223 | Rel | Full | 8/2 [75] | > 100% | Wed 09 (w2,4,6,9-10,12, MathewsThA) Comb/w PHPH2101 PHPH2121 |
TUT | W09B | 6224 | Rel | Full | 30/30 [75] | 100% | Wed 09 (w2,4,6,9-10,12, Biomed ThC) Comb/w PHPH2101 PHPH2121 |
TUT | W09C | 6225 | Rel | Open | 15/16 [75] | 94% | Wed 09 (w2,4,6,9-10,12, Biomed ThD) Comb/w PHPH2101 PHPH2121 |
TUT | W09D | 6226 | Rel | Full | 15/2 [75] | > 100% | Wed 09 (w2,4,6,9-10,12, Biomed ThF) Comb/w PHPH2101 PHPH2121 |
TUT | W09E | 6227 | Rel | Full | 14/1 [75] | > 100% | Wed 09 (w2,4,6,9-10,12, Biomed ThA) Comb/w PHPH2101 PHPH2121 |
TUT | W09F | 6228 | Rel | Open | 10/15 [75] | 67% | Wed 09 (w2,4,6,9-10,12, Biomed ThE) Comb/w PHPH2101 PHPH2121 |
PHPH3121 | Membrane & Cellular Physiology | ||||||
LAB | W14A | 5313 | Rel | Open | 39/60 | 65% | Wed 14-17 (Wurth 202) |
LEC | A | 5312 | Auto | Open | 39/60 | 65% | Tue 14 (Biomed ThB); Tue 16-18 (Biomed ThE) |
TLB | W14B | 5314 | Rel | Open | 39/60 | 65% | Wed 14-17 (w2,3-4, Wurth 202) |
TUT | W14C | 5315 | Enr | Open | 13/15 | 87% | Wed 14-16 (w5,7-8,10, Mat 921) |
TUT | W14D | 5316 | Enr | Open | 12/15 | 80% | Wed 14-16 (w5,7-8,10, Mat 301) |
TUT | W14E | 5317 | Enr | Open | 9/15 | 60% | Wed 14-16 (w5,7-8,10, Mat 421) |
TUT | W14F | 5318 | Enr | Open | 5/15 | 33% | Wed 14-16 (w5,7-8,10, Mat 420) |
PHPH3211 | Cardiovascular Physiology and | ||||||
LAB | M14A | 5320 | Auto | Full | 45/45 | 100% | Mon 14-17 (w4-5,10, MedLb M210) |
LAB | W14A | 5321 | Auto | Open | 39/45 | 87% | Wed 14-17 (w4-5,10, MedLb M210) |
LEC | A | 5319 | Rel | Open | 84/90 | 93% | Wed 10-12 (w1, Biomed ThA); Wed 10-12 (w1,2,4,5-7,8,10, Biomed ThA); Wed 10-12 (w2, Biomed ThA); Wed 10-12 (w2,12, Biomed ThA); Wed 10-12 (w3, Biomed ThA); Wed 10-12 (w4, Biomed ThA); Wed 10-12 (w8, Biomed ThA); Wed 10-12 (w9, Biomed ThA); Wed 10-12 (w10, Biomed ThA); Wed 10-12 (w11, Biomed ThA); Wed 10-12 (w12, Biomed ThA); Wed 13 (w1, Biomed ThB); Wed 13 (w1,2,4,5-7,8,10, Biomed ThB); Wed 13 (w2, Biomed ThB); Wed 13 (w2,12, Biomed ThB); Wed 13 (w3, Biomed ThB); Wed 13 (w4, Biomed ThB); Wed 13 (w8, Biomed ThB); Wed 13 (w9, Biomed ThB); Wed 13 (w10, Biomed ThB); Wed 13 (w11, Biomed ThB); Wed 13 (w12, Biomed ThB) |
OTH | H16A | 5323 | Rel | Open | 43/45 | 96% | |
OTH | H17A | 5322 | Rel | Open | 41/45 | 91% | |
TLB | M14B | 5324 | Rel | Full | 45/45 | 100% | Mon 14-17 (w2,6,11, Wurth 204); Mon 14-17 (w7-8,11, Wurth 204) |
TLB | W14B | 5325 | Rel | Open | 39/45 | 87% | Wed 14-17 (w7-8, Wurth 202); Wed 14-17 (w2,6,11, Wurth 204); Wed 14-17 (w11, Wurth 204) |
TUT | M14C | 5326 | Enr | Full | 16/15 | > 100% | Mon 14-16 (w1,3, Mat 104) |
TUT | M14D | 5327 | Enr | Full | 15/15 | 100% | Mon 14-16 (w1,3, Mat 309) |
TUT | M14E | 5328 | Enr | Open | 14/15 | 93% | Mon 14-16 (w1,3, Mat 107) |
TUT | W14C | 5329 | Enr | Full | 15/15 | 100% | Wed 14-16 (w1,3, Mat 308) |
TUT | W14D | 5330 | Enr | Open | 13/15 | 87% | Wed 14-16 (w1,3, Mat 309) |
TUT | W14E | 5331 | Enr | Open | 11/15 | 73% | Wed 14-16 (w1,3, Mat 104) |
PHPH3251 | Clinical & Exp'l Pharmacology | ||||||
LAB | M11A | 5333 | Enr | Open | 61/70 | 87% | Mon 11-14 (w1,4,7-8,10, Wurth 204); Mon 11-14 (w2,3,5-6,11-12, Wurth 204) |
LEC | A | 5332 | Auto | Open | 61/90 | 68% | Tue 15 (Biomed ThD); Thu 15 (Biomed ThB) |
TLB | M09A | 5334 | Rel | Open | 61/90 | 68% | Mon 09-12 (w9, WurthG2/G4) |
TUT | H11A | 5335 | Rel | Open | 61/70 | 87% | Thu 11-13 (Wurth 501) |
PHPH3502 | Skeletal Muscle in Hlth&Exer. | ||||||
LAB | M15A | 6230 | Rel | Open | 16/45 | 36% | Mon 15-18 (w3-5,10, Wurth 204) |
LEC | A | 6229 | Rel | Open | 16/45 | 36% | Fri 09-12 (Biomed ThA) |
SEM | H14A | 6231 | Enr | Open | 16/45 | 36% | Thu 14-17 (Biomed ThA) |
PHPH4218 | Physiology Honours Full-Time | ||||||
HON | 0001 | 9342 | Enr | Open* | 6/30 | 20% | |
PHPH4224 | Physiology Honours Part-Time | ||||||
HON | 0001 | 9344 | Enr | Open* | 0/30 | 0% | |
PHPH4258 | Pharmacology Honours Full-Time | ||||||
HON | 0001 | 9345 | Enr | Open* | 13/30 | 43% | |
PHPH4264 | Pharmacology Honours Part-Time | ||||||
HON | 0001 | 9346 | Enr | Open* | 0/30 | 0% | |
PHPH5394 | (P/T) Research Thesis Physiol | ||||||
THE | 0001 | 2148 | Enr | Open* | 5/30 | 17% | |
PHPH5398 | (F/T) Research Thesis Physiol | ||||||
THE | 0001 | 2115 | Enr | Open | 26/2000 | 1% | |
PHPH5401 | Sports Injuries 1 | ||||||
DST | 0001 | 8734 | Enr | Open | 0/30 | 0% | |
DST | 01 | 9945 | Enr | Open* | 0/30 | 0% | |
PHPH5411 | Sports Injuries 2 | ||||||
DST | 0001 | 8736 | Enr | Open | 0/30 | 0% | |
PHPH5420 | Sports Psychology | ||||||
DST | 0001 | 8737 | Enr | Open | 6/30 | 20% | |
PHPH5421 | Sports Injuries 3 | ||||||
DST | 0001 | 8738 | Enr | Open | 7/30 | 23% | |
PHPH5431 | Med Applications of Exercise 1 | ||||||
LEC | 0001 | 8739 | Enr | Open | 3/30 | 10% | |
PHPH5440 | Clinical Skills Training 1 | ||||||
WRK | 0001 | 8740 | Enr | Open | 20/30 | 67% | |
PHPH5445 | Research Project and Report | ||||||
DST | 0001 | 8741 | Enr | Open | 1/30 | 3% | |
PHPH5450 | Clinical Skills Training 2 | ||||||
WRK | 0001 | 8742 | Enr | Open | 8/30 | 27% | |
PHPH5453 | Major Project and Report | ||||||
DST | 0001 | 8744 | Enr | Open* | 2/30 | 7% | |
PHPH5470 | Sports Nutrition | ||||||
DST | 0001 | 8745 | Enr | Open | 6/30 | 20% | |
PHPH5510 | Sports Pharmacology | ||||||
DST | 0001 | 8811 | Enr | Open | 5/30 | 17% | |
PHPH5530 | Clinical Biomechanics | ||||||
DST | 0001 | 8812 | Enr | Open | 6/30 | 20% | |
PHPH5571 | Research Methods | ||||||
DST | 0001 | 8814 | Enr | Open | 4/30 | 13% | |
PHPH5591 | Paediatric Sports Medicine | ||||||
DST | 0001 | 8813 | Enr | Open | 3/30 | 10% | |
PHPH5611 | Applied Sports Medicine | ||||||
DST | 0001 | 8810 | Enr | Open | 4/30 | 13% | |
PHPH9101 | Principles of Drug Action | ||||||
LEC | 0001 | 8815 | Enr | Open | 37/50 | 74% | |
PHPH9102 | Pharm. Develp of New Medicines | ||||||
LEC | 0001 | 8816 | Enr | Open | 39/40 | 98% | |
PHPH9107 | Therapeutics & Molec Basis of | ||||||
LEC | 0001 | 8817 | Enr | Open | 10/30 | 33% | |
PHPH9111 | Pharmaceutical Formulation 2 | ||||||
LEC | 0001 | 8822 | Enr | Open | 8/30 | 27% | |
PHPH9114 | Pharmacoeconomics | ||||||
LEC | 0001 | 8818 | Enr | Open | 11/30 | 37% | |
PHPH9118 | Therap&Molec Basis of Disease2 | ||||||
LEC | 0001 | 8821 | Enr | Open | 10/30 | 33% | |
PHPH9121 | Postmarketing Development Med | ||||||
LEC | 0001 | 8820 | Enr | Open | 41/50 | 82% | |
PHPH9127 | Safety and Efficacy | ||||||
OTH | 0001 | 8819 | Enr | Open | 39/60 | 65% | |
^ top ^ | |||||||
LEGEND | |||||||
* This class requires consent. Students cannot self-enrol. | |||||||
# Timetable clash allowed. | |||||||
/odd Runs in odd weeks only. /even Runs in even weeks only. | |||||||
Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity. | |||||||
Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes. | |||||||
[ ] Class capacity where different from effective capacity. | |||||||
Shaded cells: | LEC | Activity different from previous | |||||
Stop | Status is Stop Further Enrolment, Tentative, Closed or Cancelled | ||||||
100% | Class is full (> 100% means capacity is exceeded) | ||||||
80% | Class is nearly full (80% or more) | ||||||
50% | Class is half full | ||||||
0% | Class is less than half full | ||||||
UNSW Sydney NSW 2052, Australian Telephone: (within Aust) 02 9385 1000, (International) +61 2 9385 1000 CRICOS Provider Code 00098G Authorised by Deputy Vice Chancellor (Academic) & Registrar Privacy Statement Copyright & Disclaimer |